
# [Patrick Bryant](https://patrickbryantlab.github.io)
I'm an assistant professor at [Stockholm University](https://www.su.se/department-of-molecular-biosciences-the-wenner-gren-institute/) and [SciLifeLab](https://www.scilifelab.se). \
In my team, we develop the drugs of the future: [Peptides](https://en.wikipedia.org/wiki/Peptide)
- Dedicated scientist
- For a healthier future

[<img src="https://img.icons8.com/?size=100&id=79076&format=png&color=000000" width="3.5%"/>](https://scholar.google.com/citations?user=KPlaFQQAAAAJ&hl=en&oi=ao) &nbsp;
[<img src="https://img.icons8.com/color/48/000000/twitter.png" width="3.5%"/>](https://twitter.com/Patrick18287926)  &nbsp;
[<img src="https://img.icons8.com/color/48/000000/linkedin.png" width="3.5%"/>](https://www.linkedin.com/in/patrick-bryant-phd/) &nbsp;
<a href="mailto:patrick.bryant@scilifelab.se"> <img src="https://img.icons8.com/fluent/48/000000/gmail.png" width="3.5%"/>

[More about the lab](https://patrickbryantlab.github.io)

#### Favourite Software from my team right now: [RareFold](https://github.com/patrickbryant1/RareFold)

<div align="left">
    <details>
        <summary><b>GitHub Metrics</b></summary>
    <br>

[![Stats](https://github-readme-stats.vercel.app/api?username=patrickbryant1&show_icons=true)](https://github-readme-stats.vercel.app/api?username=patrickbryant1&show_icons=true&theme=radical)&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;
</div>

<div align="left">
    <details>
        <summary><b>Latest Research</b></summary>
    <br>
    [!
    1. [Li Q, Daumiller D, Bryant P. RareFold: Structure prediction and design of proteins with noncanonical amino acids. bioRxiv. 2025. p. 2025.05.19.654846. doi:10.1101/2025.05.19.654846](https://www.biorxiv.org/content/10.1101/2025.05.19.654846v1)

    2. [Daumiller D*, Giammarino F*, Li Q, Sonnerborg A, Cena-Diez R, Bryant P. Single-Shot Design of a Cyclic Peptide Inhibitor of HIV-1 Membrane Fusion with EvoBind. bioRxiv. 2025. p. 2025.04.30.651413. doi:10.1101/2025.04.30.651413](https://www.biorxiv.org/content/10.1101/2025.04.30.651413v1)

    3. [Li Q, Wiita E, Helleday T, Bryant P. Blind De Novo Design of Dual Cyclic Peptide Agonists Targeting GCGR and GLP1R. bioRxiv. 2025. p. 2025.06.06.658268. doi: https://doi.org/10.1101/2025.06.06.658268](https://www.biorxiv.org/content/10.1101/2025.06.06.658268v1)
]
</div>
